Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Lipidor AB | 56,667 | net | 03 Nov 2020 | tx 4+70,001−13,334 |
| Lipigon Pharmaceuticals AB | 44,000 | net | 17 Jun 2022 | tx 3+44,000 |
| Ectin Research AB | 33,000 | net | 02 Sept 2021 | tx 3+33,000 |
| Ziccum | -4,000 | net | 02 Dec 2019 | tx 1−4,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 17 Jun 2022 | PURCHASE | Lipigon Pharmaceuticals AB | 24,000 | 2.15 SEK | |
| 09 Aug 2021 | PURCHASE | Ectin Research AB | 3,000 | 0.00 SEK | deriv |
| 09 Aug 2021 | PURCHASE | Ectin Research AB | 18,000 | 5.90 SEK | |
| 02 Sept 2021 | PURCHASE | Ectin Research AB | 12,000 | 6.34 SEK | |
| 21 Jun 2021 | PURCHASE | Lipigon Pharmaceuticals AB | 10,000 | 6.75 SEK | |
| 03 Nov 2020 | PURCHASE | Lipidor AB | 20,000 | 9.95 SEK | derivfirst after silence |
| 02 Dec 2019 | SALE | Lipidor AB | 13,334 | 13.37 SEK | |
| 02 Dec 2019 | SALE | Ziccum | 4,000 | 12.16 SEK | |
| 25 Sept 2019 | PURCHASE | Lipidor AB | 33,334 | 6.00 SEK | |
| 25 Sept 2019 | PURCHASE | Lipidor AB | 16,667 | 0.00 SEK | deriv |
1 purchase reported after at least 12 months of silence — most recent on 03 Nov 2020.